Literature DB >> 6776033

Analysis of the in vitro immune response to insulin. I. Primary induction of insulin-specific T helper cells and characterization of the genetic control of the helper cell response to bovine and porcine insulin.

P Erb.   

Abstract

The in vitro induction and assay of bovine or porcine insulin specific T helper cells is described. Using a modified Marbrook-Diener culture system, helper cells were generated either by incubating purified T cells with insulin and macrophages or with supernatant obtained from insulin-incubated macrophages (GRF). The macrophage-T cell interaction required for helper cell induction was genetically restricted and the genes responsible were mapped to the left of the I-B subregion of the H-2 complex. The Ir gene control of the helper cell response to insulin was examined. It was found that the H-2d T cells became helper cells if incubated with bovine or porcine insulin and the appropriate macrophages. H-2b T cells only became helper cells if incubated with bovine but not with porcine insulin and macrophages. The Ir genes controlling that response were also mapped to the left of I-B. Studies to determine the cellular sites of Ir gene expression revealed that Ir genes function at the level of macrophages, although other sites have not been excluded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776033      PMCID: PMC1458053     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Role of macrophages in in vitro induction of T-helper cells.

Authors:  P Erb; M Feldmann
Journal:  Nature       Date:  1975-03-27       Impact factor: 49.962

2.  The role of macrophages in the generation of T helper cells. III. Influence of macrophage-derived factors in helper cell induction.

Authors:  P Erb; M Feldmann
Journal:  Eur J Immunol       Date:  1975-11       Impact factor: 5.532

3.  Role of macrophages in the generation of T helper cells. IV. Nature of genetically related factor derived from macrophages incubated with soluble antigens.

Authors:  P Erb; M Feldmann; N Hogg
Journal:  Eur J Immunol       Date:  1976-05       Impact factor: 5.532

4.  Insulin-specific murine antibodies of limited heterogeneity. I. Genetic control of spectrotypes.

Authors:  J A Kapp; D S Strayer; P F Robbins; R M Perlmutter
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

5.  H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin.

Authors:  J A Kapp; D S Strayer
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

6.  Ir gene control of carrier recognition. III. Cooperative recognition of two or more carrier determinants on insulins of different species.

Authors:  K Keck
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

7.  The role of macrophages in the generation of T-helper cells. I. The requirement for macrophages in helper cell induction and characteristics of the macrophage-T cell interaction.

Authors:  P Erb; M Feldmann
Journal:  Cell Immunol       Date:  1975-10       Impact factor: 4.868

8.  Is genetically related macrophage factor (GRF) a soluble immune response (Ir) gene product?

Authors:  P Erb; B Meier; M Feldmann
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

9.  Immune response gene control of determinant selection. II. Genetic control of the murine T lymphocyte proliferative response to insulin.

Authors:  L J Rosenwasser; M A Barcinski; R H Schwartz; A S Rosenthal
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

10.  Ia-bearing bone marrow-cultured macrophages induce antigen-specific helper T cells for antibody synthesis.

Authors:  A C Stern; P Erb; R H Gisler
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

View more
  1 in total

1.  Human insulin specific suppressor factors. I. Induction, characteristics and comparison to murine factors.

Authors:  S Kontiainen
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.